Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Accolade stock price, quote, forecast and news

ACCD
US00437E1029
A2P7Z2

Price

4.03
Today +/-
-0.16
Today %
-4.37 %
P

Accolade stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Accolade stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Accolade stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Accolade stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Accolade's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Accolade Stock Price History

DateAccolade Price
9/6/20244.03 undefined
9/5/20244.21 undefined
9/4/20244.16 undefined
9/3/20244.24 undefined
8/30/20244.34 undefined
8/29/20244.31 undefined
8/28/20244.22 undefined
8/27/20244.33 undefined
8/26/20244.41 undefined
8/23/20244.42 undefined
8/22/20244.20 undefined
8/21/20244.33 undefined
8/20/20244.18 undefined
8/19/20244.27 undefined
8/16/20244.13 undefined
8/15/20244.15 undefined
8/14/20244.00 undefined
8/13/20244.06 undefined
8/12/20243.89 undefined

Accolade Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Accolade, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Accolade from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Accolade’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Accolade. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Accolade’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Accolade’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Accolade’s growth potential.

Accolade Revenue, EBIT and net profit per share

DateAccolade RevenueAccolade EBITAccolade Net Income
2030e1.2 B undefined0 undefined0 undefined
2029e1.02 B undefined-102,000 undefined0 undefined
2028e852.36 M undefined-27.13 M undefined37.8 M undefined
2027e616.21 M undefined-71.62 M undefined-62.32 M undefined
2026e540.46 M undefined-81.76 M undefined-76.13 M undefined
2025e476.27 M undefined-92.77 M undefined-87.39 M undefined
2024414.29 M undefined-113.6 M undefined-99.81 M undefined
2023363.1 M undefined-162.6 M undefined-459.7 M undefined
2022310 M undefined-112.5 M undefined-123.1 M undefined
2021170.4 M undefined-46.8 M undefined-50.7 M undefined
2020132.5 M undefined-48.2 M undefined-51.4 M undefined
201994.8 M undefined-54 M undefined-56.5 M undefined
201876.8 M undefined-59.5 M undefined-61.3 M undefined

Accolade Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20182019202020212022202320242025e2026e2027e2028e2029e2030e
0.080.090.130.170.310.360.410.480.540.620.851.021.2
-23.6840.4328.7982.3517.1014.0514.9813.4514.0738.3119.8417.73
30.2636.1743.9444.7145.4845.1846.38------
23345876141164192000000
-59-54-48-46-112-162-113-92-81-71-2700
-77.63-57.45-36.36-27.06-36.13-44.63-27.29-19.33-15.00-11.53-3.17--
-61-56-51-50-123-459-99-87-76-623700
--8.20-8.93-1.96146.00273.17-78.43-12.12-12.64-18.42-159.68--
47474729.463.871.374.91000000
-------------
Details

Keystats

ⓘ

Revenue and Growth

The Accolade Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Accolade is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
201820192020202120222023
           
13.542.733.2433.9365.9321.1
70.41.211.830.826.7
000000
000000
2.93.714.58.312.518.1
23.446.848.9454409.2365.9
21.515.313.69.244.944.3
000000
000000
002.10.6244.7203.2
0044577.9278.2
2.23.64.67.78.911.4
23.718.924.321.5876.4537.1
0.050.070.070.481.290.9
           
167214.7233000
0.030.040.060.761.351.43
-213-269.5-320.9-371.5-494.6-954.3
000000
000000
-16.7-15.9-23.8390.9855.8473.8
1.62.55.37.47.810.2
19.622.830.440.247.450.9
15.331.534.331.555.957.8
000000
50000.60.6
41.556.87079.1111.7119.5
15.919.221.10280.7282.3
000000
6.45.95.95.637.327.5
22.325.1275.6318309.8
63.881.99784.7429.7429.3
0.050.070.070.481.290.9
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Accolade provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Accolade's financial health and stability.

Assets

Accolade's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Accolade must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Accolade after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Accolade's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201820192020202120222023
-61-56-51-50-123-459
79884246
0000-6-4
425-53-7-1
18102023105450
122201
000000
-38-16-34-25-62-40
-7-3-3-2-3-7
-7-3-3-2-263-7
0000-2600
000000
14-21-222870
05026451134
1548284282573
-----42.00-1.00
000000
-3029-9400-68-44
-45.44-19.67-37.57-27.6-65.97-47.94
000000

Accolade stock margins

The Accolade margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Accolade. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Accolade.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Accolade's sales revenue. A higher gross margin percentage indicates that the Accolade retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Accolade's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Accolade's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Accolade's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Accolade. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Accolade's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Accolade Margin History

Accolade Gross marginAccolade Profit marginAccolade EBIT marginAccolade Profit margin
2030e46.52 %0 %0 %
2029e46.52 %-0.01 %0 %
2028e46.52 %-3.18 %4.43 %
2027e46.52 %-11.62 %-10.11 %
2026e46.52 %-15.13 %-14.09 %
2025e46.52 %-19.48 %-18.35 %
202446.52 %-27.42 %-24.09 %
202345.22 %-44.78 %-126.6 %
202245.48 %-36.29 %-39.71 %
202145.01 %-27.46 %-29.75 %
202044.38 %-36.38 %-38.79 %
201936.08 %-56.96 %-59.6 %
201830.47 %-77.47 %-79.82 %

Accolade Stock Sales Revenue, EBIT, Earnings per Share

The Accolade earnings per share therefore indicates how much revenue Accolade has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Accolade earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Accolade's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Accolade’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Accolade's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Accolade Revenue, EBIT and net profit per share

DateAccolade Sales per ShareAccolade EBIT per shareAccolade Earnings per Share
2030e15.25 undefined0 undefined0 undefined
2029e12.95 undefined0 undefined0 undefined
2028e10.81 undefined0 undefined0.48 undefined
2027e7.82 undefined0 undefined-0.79 undefined
2026e6.86 undefined0 undefined-0.97 undefined
2025e6.04 undefined0 undefined-1.11 undefined
20245.53 undefined-1.52 undefined-1.33 undefined
20235.09 undefined-2.28 undefined-6.45 undefined
20224.86 undefined-1.76 undefined-1.93 undefined
20215.8 undefined-1.59 undefined-1.72 undefined
20202.82 undefined-1.03 undefined-1.09 undefined
20192.02 undefined-1.15 undefined-1.2 undefined
20181.63 undefined-1.27 undefined-1.3 undefined

Accolade business model

Accolade Inc is a US-American company based in Seattle. The company was founded in 2007 by Rajeev Singh and Mike Hilton and has since developed into a leading healthcare consulting firm. Accolade aims to make healthcare simple and affordable for everyone. The company offers a wide range of solutions to its customers. It provides services to employers, insurance companies, and health authorities. Their main focus is on supporting patients and employees in their healthcare. They also offer services to health insurance companies and health authorities. The business model of Accolade involves close collaboration between the customers and the company. Patients are supported by a "Health Assistant," who are trained professionals that help patients make the best decisions regarding their health. Factors such as finding the best providers, medication delivery, clinical tests, and alternative options are considered. Accolade's mission is to improve healthcare for everyone by providing the best solutions. The company has divided itself into several different divisions to offer its services more effectively. The various divisions of Accolade include healthcare consulting, medication management, patient access and health navigation, client support, and health optimization. Accolade has become an important healthcare service provider and has earned a good reputation in the industry. The company is known for providing comprehensive and high-quality services that focus on individual patient care. When it comes to achieving improvements in care and the entire healthcare system, Accolade is an important partner that helps companies and individuals achieve their goals and lead healthier lives. Accolade is one of the most popular companies on Eulerpool.com.

Accolade SWOT Analysis

Strengths

Accolade Inc. has several strengths that contribute to its success in the market. These include:

  • Strong brand reputation: Accolade Inc. is widely recognized and respected in the industry.
  • Diverse product portfolio: The company offers a wide range of products, catering to different customer needs.
  • Innovative technology: Accolade Inc. continually invests in research and development, resulting in cutting-edge products and solutions.
  • Strong financial position: The company has a solid financial foundation, allowing it to withstand market fluctuations and invest strategically.
  • Strong customer base: Accolade Inc. has established long-term relationships with a large and loyal customer base.

Weaknesses

Despite its strengths, Accolade Inc. also faces certain weaknesses that may hinder its growth and success:

  • Dependence on key customers: The loss of a major customer could significantly impact the company's financial performance.
  • Limited international presence: Accolade Inc. primarily operates in domestic markets, which may restrict its growth opportunities.
  • Reliance on third-party suppliers: The company relies on external suppliers for certain key components, making it susceptible to supply chain disruptions.
  • High competition: The industry in which Accolade Inc. operates is highly competitive, requiring continuous innovation and differentiation.
  • Dependence on specific market segments: Accolade Inc.'s success depends on specific market segments, making it vulnerable to changes in consumer preferences.

Opportunities

Accolade Inc. can leverage various opportunities to enhance its market position and drive growth:

  • Expansion into new markets: Exploring untapped domestic and international markets can help diversify the company's revenue streams.
  • Technological advancements: The increasing demand for technologically advanced products presents opportunities for Accolade Inc. to develop innovative solutions.
  • Increase in healthcare spending: Rising healthcare expenditures create a favorable environment for Accolade Inc. to offer premium products and services.
  • Partnerships and collaborations: Collaborating with other industry leaders or forming strategic alliances can expand Accolade Inc.'s market reach and capabilities.
  • Changing regulatory landscape: Adapting to evolving regulations and compliance requirements can create opportunities for Accolade Inc. to gain a competitive edge.

Threats

Accolade Inc. faces several threats that pose risks to its business and market position:

  • Intense market competition: The industry is characterized by fierce competition, with numerous players vying for market share.
  • Economic downturns: Economic instability and recessions can impact consumer spending, potentially leading to a decline in demand for Accolade Inc.'s products.
  • Rapid technological advancements: Failure to keep pace with technological changes may render Accolade Inc.'s products obsolete or less desirable in the market.
  • Changing healthcare policies: Shifts in healthcare policies and regulations may affect reimbursement rates or market access for Accolade Inc.'s products.
  • Supply chain disruptions: Disruptions in the supply chain, such as natural disasters or geopolitical issues, can disrupt production and compromise product availability.

Accolade Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Accolade historical P/E ratio, EBIT, and P/S ratio.

Accolade shares outstanding

The number of shares was Accolade in 2023 — This indicates how many shares 71.3 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Accolade earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Accolade's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Accolade’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Accolade's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Accolade.

Accolade latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.49 -0.35  (28.86 %)2025 Q1
3/31/2024-0.07 -0.1  (-38.5 %)2024 Q4
12/31/2023-0.45 -0.28  (37.92 %)2024 Q3
9/30/2023-0.55 -0.43  (21.42 %)2024 Q2
6/30/2023-0.63 -0.52  (17.76 %)2024 Q1
3/31/2023-0.43 -0.42  (2.67 %)2023 Q4
12/31/2022-0.63 -0.56  (11.24 %)2023 Q3
9/30/2022-0.74 -0.66  (10.67 %)2023 Q2
6/30/2022-0.68 -0.62  (9.42 %)2023 Q1
3/31/2022-0.36 -0.51  (-40.23 %)2022 Q4
1
2

Eulerpool ESG Scorecard© for the Accolade stock

Eulerpool World ESG Rating (EESG©)

38/ 100

🌱 Environment

18

👫 Social

50

🏛️ Governance

45

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees70
Percentage of women in management—
Percentage of Asian employees7.1
Share of Asian management9.9
Percentage of Hispanic/Latino employees10.1
Hispano/Latino Management share7.1
Percentage of Black employees20.8
Black Management Share10.3
Percentage of white employees58.1
White Management Share69.9
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety❌
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Accolade list of shareholders

%
Name
Stocks
Change
Date
7.56288 % Brown Advisory5,962,571-103,51812/31/2023
7.11954 % ARK Investment Management LLC5,613,043-1,192,1653/31/2024
6.84768 % Andreessen Horowitz5,398,708012/31/2023
6.84768 % Ah Capital Management LLC (Sibling)5,398,7085,398,70812/31/2023
6.74121 % The Vanguard Group, Inc.5,314,77342,35412/31/2023
6.20565 % BlackRock Institutional Trust Company, N.A.4,892,535288,36412/31/2023
5.71715 % Bellevue Asset Management AG4,507,404-20,51912/31/2023
4.55745 % JP Morgan Asset Management3,593,096-16,91012/31/2023
4.42035 % Rock Springs Capital Management LP3,485,000572,00012/31/2023
3.30029 % JPMorgan Asset Management U.K. Limited2,601,945-49,74512/31/2023
1
2
3
4
5
...
10

Accolade Executives and Management Board

Mr. Rajeev Singh55
Accolade Chairman of the Board, Chief Executive Officer (since 2015)
Compensation 2 M
Mr. Stephen Barnes52
Accolade Chief Financial Officer
Compensation 1.14 M
Mr. Robert Cavanaugh54
Accolade President
Compensation 1.13 M
Mr. Michael Hilton59
Accolade Director (since 2015)
Compensation 691,772
Mr. Peter Klein61
Accolade Lead Independent Director
Compensation 262,000
1
2
3

Accolade Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
American Airlines Group Stock
American Airlines Group
SupplierCustomer0,530,48-0,100,180,78-
Lowe's Stock
Lowe's
SupplierCustomer0,410,470,710,89-0,30-
Change Healthcare Stock
Change Healthcare
SupplierCustomer0,300,39-0,48-0,66--
Premier A Stock
Premier A
SupplierCustomer0,230,16-0,460,58-0,04-
Amazon.com Stock
Amazon.com
SupplierCustomer0,080,180,420,650,59-
Comcast A Stock
Comcast A
SupplierCustomer-0,010,220,440,710,92-
Alphabet A Stock
Alphabet A
SupplierCustomer-0,030,290,640,76-0,13-
Limeade CDI Stock
Limeade CDI
SupplierCustomer-0,180,010,190,750,92-
1

Most common questions regarding Accolade

What values and corporate philosophy does Accolade represent?

Accolade Inc represents values of innovation, collaboration, and customer-centricity. With a strong corporate philosophy focused on improving healthcare experiences, Accolade Inc strives to empower individuals and families to navigate their health and benefits in a personalized and effective manner. By combining technology and human expertise, the company aims to deliver comprehensive support, enhance outcomes, and reduce healthcare costs. Accolade Inc's commitment to delivering exceptional service and its emphasis on providing personalized health advocacy aligns with its mission to empower individuals and transform the healthcare industry.

In which countries and regions is Accolade primarily present?

Accolade Inc is primarily present in the United States of America.

What significant milestones has the company Accolade achieved?

Accolade Inc has achieved several significant milestones since its inception. The company successfully completed its initial public offering (IPO) in July 2020, marking a major achievement in its growth trajectory. In recent years, Accolade Inc has formed strategic partnerships with various renowned healthcare organizations, enhancing its market presence and enabling provision of personalized healthcare solutions. With its innovative technology and dedicated team, Accolade Inc has rapidly expanded its customer base, serving millions of individuals across the United States. The company's revolutionary approach to healthcare management has garnered recognition, including being named a Fast Company's Most Innovative Company in 2021. Accolade Inc continues to drive innovation in the healthcare industry, revolutionizing the way individuals access and navigate their healthcare choices.

What is the history and background of the company Accolade?

Accolade Inc, founded in 2007, is a leading technology-enabled healthcare company headquartered in Seattle, Washington. The company provides personalized healthcare and benefits solutions to its clients, including employers, health plans, and health systems. With a mission to improve the healthcare experience for individuals and their families, Accolade Inc combines cutting-edge technology and human expertise to deliver personalized health and benefits services. Over the years, Accolade Inc has established itself as a trusted partner in the industry, leveraging their deep domain knowledge and innovative solutions to support individuals in navigating the complex healthcare landscape efficiently and effectively. This commitment to customer-centric healthcare has propelled Accolade Inc to become a recognized leader in the industry.

Who are the main competitors of Accolade in the market?

Accolade Inc faces competition from various companies in the market. Some of its main competitors include Teladoc Health, Livongo Health, and Health Catalyst. These companies also operate in the healthcare technology sector, providing similar services and solutions. However, Accolade Inc distinguishes itself through its unique combination of personal health support and advanced technology platforms, offering a comprehensive approach to healthcare management and improving patient outcomes.

In which industries is Accolade primarily active?

Accolade Inc is primarily active in the healthcare and technology industries.

What is the business model of Accolade?

Accolade Inc operates as a healthcare technology and services company. The company's business model is based on providing personalized health and benefits solutions to individuals and their families. Accolade's services include healthcare navigation, behavioral health support, benefits advisory, and chronic condition management. By combining technology and human touch, Accolade aims to simplify and improve access to healthcare for its clients. Through their platform, Accolade Inc aims to empower individuals in making informed healthcare decisions, managing their health conditions, and optimizing their overall well-being. Accolade Inc strives to enhance healthcare outcomes and reduce costs for both individuals and employers.

What is the P/E ratio of Accolade 2024?

The Accolade P/E ratio is -3.02.

What is the P/S ratio of Accolade 2024?

The Accolade P/S ratio is 0.73.

What is the AlleAktien quality score of Accolade?

The AlleAktien quality score for Accolade is 4/10.

What is the revenue of Accolade 2024?

The Accolade revenue is 414.29 M USD.

How high is the profit of Accolade 2024?

The Accolade profit is -99.81 M USD.

What is the business model of Accolade

Accolade is a technology and healthcare company that develops innovative solutions for improving healthcare.

What is the Accolade dividend?

Accolade pays a dividend of 0 USD distributed over payouts per year.

How often does Accolade pay dividends?

The dividend cannot currently be calculated for Accolade or the company does not pay out a dividend.

What is the Accolade ISIN?

The ISIN of Accolade is US00437E1029.

What is the Accolade WKN?

The WKN of Accolade is A2P7Z2.

What is the Accolade ticker?

The ticker of Accolade is ACCD.

How much dividend does Accolade pay?

Over the past 12 months, Accolade paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Accolade is expected to pay a dividend of 0 USD.

What is the dividend yield of Accolade?

The current dividend yield of Accolade is .

When does Accolade pay dividends?

Accolade pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Accolade?

Accolade paid dividends every year for the past 0 years.

What is the dividend of Accolade?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Accolade located?

Accolade is assigned to the 'Health' sector.

Wann musste ich die Aktien von Accolade kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Accolade from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did Accolade pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of Accolade in the year 2023?

In the year 2023, Accolade distributed 0 USD as dividends.

In which currency does Accolade pay out the dividend?

The dividends of Accolade are distributed in USD.

All fundamentals about Accolade

Our stock analysis for Accolade Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Accolade Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.